Jacobs & Co. CA Sells 125 Shares of Colgate-Palmolive (NYSE:CL)

Jacobs & Co. CA lessened its holdings in shares of Colgate-Palmolive (NYSE:CL) by 1.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,938 shares of the company’s stock after selling 125 shares during the quarter. Jacobs & Co. CA’s holdings in Colgate-Palmolive were worth $632,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of CL. IFG Advisory LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth $208,000. OmniStar Financial Group Inc. grew its stake in shares of Colgate-Palmolive by 7.4% in the 4th quarter. OmniStar Financial Group Inc. now owns 6,341 shares of the company’s stock worth $506,000 after acquiring an additional 437 shares in the last quarter. PFG Investments LLC grew its stake in shares of Colgate-Palmolive by 5.4% in the 4th quarter. PFG Investments LLC now owns 14,610 shares of the company’s stock worth $1,165,000 after acquiring an additional 745 shares in the last quarter. Sandy Cove Advisors LLC grew its stake in shares of Colgate-Palmolive by 0.9% in the 4th quarter. Sandy Cove Advisors LLC now owns 15,481 shares of the company’s stock worth $1,234,000 after acquiring an additional 145 shares in the last quarter. Finally, Heartwood Wealth Advisors LLC grew its stake in shares of Colgate-Palmolive by 35.3% in the 4th quarter. Heartwood Wealth Advisors LLC now owns 4,626 shares of the company’s stock worth $369,000 after acquiring an additional 1,208 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling

In related news, insider Jennifer Daniels sold 61,633 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $83.93, for a total value of $5,172,857.69. Following the transaction, the insider now directly owns 57,948 shares in the company, valued at $4,863,575.64. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of the stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the transaction, the director now directly owns 19,272 shares in the company, valued at $1,628,484. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jennifer Daniels sold 61,633 shares of the stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $83.93, for a total transaction of $5,172,857.69. Following the transaction, the insider now owns 57,948 shares in the company, valued at $4,863,575.64. The disclosure for this sale can be found here. Over the last three months, insiders have sold 232,371 shares of company stock worth $19,505,099. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Trading Up 1.2 %

Shares of Colgate-Palmolive stock opened at $89.96 on Thursday. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $90.27. The company has a market cap of $74.05 billion, a price-to-earnings ratio of 32.36, a PEG ratio of 3.38 and a beta of 0.42. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59. The company’s 50-day moving average price is $85.34 and its 200-day moving average price is $78.98.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 26th. The company reported $0.87 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.02. The company had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.89 billion. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. Colgate-Palmolive’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.77 earnings per share. On average, equities analysts expect that Colgate-Palmolive will post 3.49 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.22%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio is 69.06%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on CL shares. Morgan Stanley upped their target price on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research note on Monday, January 29th. JPMorgan Chase & Co. boosted their price target on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a report on Thursday, January 18th. Wells Fargo & Company boosted their price target on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a report on Monday, January 29th. Raymond James raised shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target on the stock in a report on Monday, January 29th. Finally, UBS Group upped their price objective on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a report on Monday, January 29th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $87.31.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.